Filing Details
- Accession Number:
- 0001555280-24-000339
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-26 16:27:48
- Reporting Period:
- 2024-11-25
- Accepted Time:
- 2024-11-26 16:27:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1555280 | Zoetis Inc. | ZTS | Pharmaceutical Preparations (2834) | 460696167 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1900620 | J Robert Polzer | C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-25 | 1,057 | $160.62 | 4,306 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-11-25 | 2,420 | $162.07 | 6,726 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-25 | 3,477 | $177.46 | 3,249 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2024-11-25 | 1,057 | $0.00 | 1,057 | $0.00 |
| Common Stock | Stock Option | Disposition | 2024-11-25 | 2,420 | $0.00 | 2,420 | $162.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,455 | No | 4 | M | Direct | ||
| 4,840 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,060 | Indirect | 401(k) |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | $196.14 | 7,107 | 7,107 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 7,107 | 7,107 | Direct |
Footnotes
- The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.45 to $177.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Represents the common stock equivalents held in the Zoetis Inc. Savings Plan, a 401(k) plan, as of September 30, 2024.
- Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
- 1,057 options granted February 10, 2021 at an exercise price of $160.62 per option.
- Each option vests on the third anniversary of the date of grant.
- Each option expires on the tenth anniversary of the date of grant.
- 5,455 options granted February 8, 2022 at an exercise price of $201.30 per option.
- Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
- One-third of each option vests on the first, second and third anniversaries of the date of grant, February 8, 2023.
- One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 6, 2024.
Billionaire Hedge Funds
